Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Asian Pac J Cancer Prev ; 19(7): 1785-1792, 2018 Jul 27.
Article in English | MEDLINE | ID: mdl-30049188

ABSTRACT

In the perspective of selenium as an antioxidant and anti-carcinogen, so far no strong intervention trials with selenium over radiation-treated oral squamous cell carcinoma cases have been conducted, to examine the response of the disease and the subsequent biochemical alterations. In the present study, untreated oral cancer cases (Gp II) were compared with radiation-treated groups with and without selenium (Gp IIa, IIb), forward to find the trace elements and cancer biomarkers status, at a follow-up of 6 months. Severe alteration in the trace elements levels of Se, Cu, Fe, Zn, Na, K, Ca, Cl, were noticed in Gp II. Though Gp IIa showed slight improvement, administration of selenium (Gp IIb) improved the level of all these elements to a greater extent (p<0.001). GpII and IIa showed increased level of bio markers 5'-nucleotidase, PschE, LAP, γ-GTP, LDH, SGOT, SGPT, ACP, ALP, CPK, TNF, CEA, AFP, Scc-Ag. The greater extent of restitution to near normalcy was observed in patients given selenium (Gp IIb) (p<0.001). Owing to the fact that selenium scavengers oxidants and hence decelerate carcinogenesis by eliminating tumors, so the tumor released constituents into the systemic circulation declined significantly. Therefore, the outcome of the study suggests selenium as a valuable therapeutic measure as adjuvant for oral cancer patients undergoing cancerocidal radiotherapy.


Subject(s)
Antioxidants/administration & dosage , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/metabolism , Homeostasis , Mouth Neoplasms/metabolism , Selenium/administration & dosage , Trace Elements/metabolism , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Case-Control Studies , Follow-Up Studies , Humans , Mouth Neoplasms/drug therapy , Mouth Neoplasms/pathology , Mouth Neoplasms/radiotherapy , Oxidative Stress , Prognosis , Radiotherapy , Selenium/blood
2.
Asian Pac J Cancer Prev ; 17(5): 2527-33, 2016.
Article in English | MEDLINE | ID: mdl-27268624

ABSTRACT

Sensitising cancer cells and at the same time desensitizing normal cells is a double task in cancer management. Agents which can combat the debilitating side effects of cancer therapeutics and simultaneously synergize with anticancer agents in specifically targeting cancer cells are needed. Selenium, a proven anticarcinogen, gains due importance in terms of its efficacy to combat the side effects of cancer therapy. This study is a comparative analysis of the chemoprotective effects of selenium compounds, methyl selenol (generated from organic selenomethionine (5mmol/L ; METase 40U/L)) and sodium selenite (inorganic form)(30µM) in peripheral blood human lymphocytes exposed to cisplatin and mitomycin. Biochemical alterations occurring in many cells during apoptosis include loss of plasma membrane phospholipid asymmetry, DNA fragmentation, and activation of caspase-3. The present study demonstrated that the selenium metabolite and selenite are efficient in protecting lymphocytes undergoing DNA damage and exerted their activity by reducing caspase 3 expression. Interestingly organic methylselenol (MeSe) was found to offer more protective effects compared to inorganic selenite (SeL), by reducing the induction of apoptosis by the cytotoxic agents. This suggests that MeSe and to a lesser extent selenite might have potential for assessment in clinical trials and could be considered as strong candidates in pharmacogenomics or in the nutriprotective arena.


Subject(s)
Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Apoptosis/drug effects , Lymphocytes/drug effects , Lymphocytes/pathology , Selenium/chemistry , Selenium/pharmacology , Caspase 3/metabolism , Cell Proliferation/drug effects , Cells, Cultured , DNA Damage/drug effects , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Humans , Lymphocytes/metabolism
3.
J Cancer Res Ther ; 11(1): 181-90, 2015.
Article in English | MEDLINE | ID: mdl-25879359

ABSTRACT

INTRODUCTION: We set out to assess whether selenium, an antioxidant mineral could influence radiogenic collagen maturation. MATERIALS AND METHODS: The study comprise of normal (Group I), untreated oral carcinoma cases (Group II) (n = 20), cases who underwent radiotherapy (Group IIa) n = 10 and cases supplemented with selenium along with radiotherapy (Group IIb) n = 10. RESULTS: Spectrophotometric estimation and luminescence spectral assignment of collagen showed improved collagen maturation status. Measurement of the mature collagen cross-links hydroxylysylpyridinoline and lysylpyridinoline by high-performance liquid chromatography on irradiated tissues showed a considerable decrease in the selenium Group IIb (P < 0.05) indicating a decrease in collagen fragments. Electron microscopic studies showed significant morphological alteration in the selenium group. The micro nucleus frequency, decreased in radiation group (P < 0.05) compared with untreated (P < 0.05). While much more decrease observed in the selenium group (P < 0.05). DISCUSSION: The results represent the effect of selenium treatment with a bearing on carcinogenic process to curtail it, thus enhancing the maturity of collagen.


Subject(s)
Antioxidants/administration & dosage , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/radiotherapy , Collagen/metabolism , Mouth Neoplasms/metabolism , Mouth Neoplasms/radiotherapy , Selenium/administration & dosage , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/ultrastructure , Dietary Supplements , Female , Flavin-Adenine Dinucleotide/metabolism , Humans , Hydroxyproline/metabolism , Male , Micronuclei, Chromosome-Defective/drug effects , Micronuclei, Chromosome-Defective/radiation effects , Mouth Neoplasms/pathology , Mouth Neoplasms/ultrastructure , Neoplasm Grading , Neoplasm Staging , Nucleic Acids/metabolism , Treatment Outcome , Tryptophan/metabolism , Tumor Burden
SELECTION OF CITATIONS
SEARCH DETAIL
...